233 related articles for article (PubMed ID: 16979430)
1. Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.
Vergote I; Amant F
Gynecol Oncol; 2006 Sep; 102(3):415-7. PubMed ID: 16979430
[No Abstract] [Full Text] [Related]
2. [Pharmacotherapy in ovarian carcinoma].
Pfisterer J; Du Bois A
MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
[TBL] [Abstract][Full Text] [Related]
3. [High dose chemotherapy: an overview in ovarian carcinoma].
Möbus VJ
Zentralbl Gynakol; 1996; 118(10):573-4. PubMed ID: 8999713
[No Abstract] [Full Text] [Related]
4. Is it time for some new approaches for treating advanced ovarian cancer?
McGuire WP
J Natl Cancer Inst; 2006 Aug; 98(15):1024-6. PubMed ID: 16882933
[No Abstract] [Full Text] [Related]
5. The ethics of early stopping rules: who is protecting whom?
Cannistra SA
J Clin Oncol; 2004 May; 22(9):1542-5. PubMed ID: 15117977
[No Abstract] [Full Text] [Related]
6. Current aspects of adjuvant therapy of early stage ovarian cancer.
McGuire WP
Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant chemotherapy in the treatment of ovarian cancer].
Lehoczky O
Orv Hetil; 2005 Sep; 146(38):1951-5. PubMed ID: 16238247
[TBL] [Abstract][Full Text] [Related]
8. Observations on the interpretation of clinical trials in early ovarian cancer.
Swart AM; Parmar MK
J Clin Oncol; 2005 Feb; 23(4):927; author reply 937-8. PubMed ID: 15681549
[No Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy improves survival after resection of stage 1 ovarian cancer.
Kitchener HC
Cancer Treat Rev; 2005 Jun; 31(4):323-7. PubMed ID: 15905036
[No Abstract] [Full Text] [Related]
10. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for high-risk early-stage endometrial cancer.
Kodama J; Seki N; Hiramatsu Y
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):42-7. PubMed ID: 17218851
[TBL] [Abstract][Full Text] [Related]
12. Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?
Munkarah A
Nat Clin Pract Oncol; 2005 Apr; 2(4):188-9. PubMed ID: 16264930
[No Abstract] [Full Text] [Related]
13. Eleven years: the long and winding road.
Ramondetta LM; Jhingran A
Gynecol Oncol; 2007 Nov; 107(2):166-8. PubMed ID: 17950382
[No Abstract] [Full Text] [Related]
14. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
Grønlund B
Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
[No Abstract] [Full Text] [Related]
15. Chemotherapy for recurrent cervical cancer.
Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma.
Trimble EL; Christian MC
Gynecol Oncol; 2006 Jan; 100(1):3-4. PubMed ID: 16368439
[No Abstract] [Full Text] [Related]
17. [Standard of chemotherapy in ovarian cancer].
Pfleiderer A; Meerpohl HG
Chirurg; 1994 Jan; 65(1):18-22. PubMed ID: 8149794
[No Abstract] [Full Text] [Related]
18. Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates.
McGuire WP
J Clin Oncol; 2009 Oct; 27(28):4633-4. PubMed ID: 19704055
[No Abstract] [Full Text] [Related]
19. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments.
Kyrgiou M; Salanti G; Pavlidis N; Paraskevaidis E; Ioannidis JP
J Natl Cancer Inst; 2006 Nov; 98(22):1655-63. PubMed ID: 17105988
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal chemotherapy for ovarian cancer.
Hamilton CA; Berek JS
Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
